Park I, Lee JL, Lee S-HL. Axitinib for recurrent or metastatic non-clear cell renal cell carcinoma. EMUC 2017, P105.
Icotinib versus chemotherapie als adjuvante behandeling stadium II-IIIA EGFR-gemuteerd NSCLC
jan 2022 | Longoncologie
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
okt 2021 | Uro-oncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
mrt 2024
nov 2023
sep 2023